1. Agreement between four high-sensitivity cardiac troponin assays and non-invasive testing, clinical and quality of care outcomes based on the 2020 ESC guidelines: results from the ROMICAT II trial. (3rd October 2022) Authors: Karady, J; Mayrhofer, T; Nagurney, J T; Udelson, J E; Fleg, J L; Peacock, W F; Januzzi, J L; Koenig, W; Ferencik, M; Hoffmann, U Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of glycated haemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE consortium. (14th October 2021) Authors: Sinning, C; Makarova, N; Schnabel, R; Ojeda, F; Felix, S B; Koenig, W; Peters, A; Rathmann, W; Brenner, H; Kuulasmaa, K; Wilsgaard, T; Blankenberg, S; Soderberg, S; Ferrario, M M; Thorand, B Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline triglycerides and non-HDL-C and apoB goal attainment in the ORION-10 and ORION-11 trials. (25th November 2020) Authors: Ray, K.K; Kallend, D; Raal, F.J; Stoekenbroek, R; Koenig, W; Leiter, L.A; Landmesser, U; Schwartz, G.G; Wijngaard, P.L.J; Kastelein, J.J.P; Wright, R.S Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. C-reactive protein as a possible modifier of Lipoprotein(a)-related risk for coronary heart disease in Europe: results from the BiomarCARE project. (3rd October 2022) Authors: Arnold, N; Blaum, C; Gossling, A; Zeller, T; Linneberg, A; Soderberg, S; Iacoviello, L; Sans, S; Leoni, V; Kee, F; Salomaa, V; Kuulasmaa, K; Blankenberg, S; Koenig, W; Waldeyer, C Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts – the BiomarCaRE project. (14th October 2021) Authors: Rehm, M; Rothenbacher, D; Iacoviello, L; Costanzo, S; Tunstall-Pedoe, H; Fitton, C.A; Soederberg, S; Hultdin, J; Salomaa, V; Palosaari, T; Waldeyer, C; Schnabel, R.B; Zeller, T; Blankenberg, S; Koenig, W Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain. Issue 11 (22nd October 2009) Authors: Manini, A F; Ilgen, J; Noble, V E; Bamberg, F; Koenig, W; Bohan, J S; Hoffmann, U Journal: Emergency medicine journal Issue: Volume 26:Issue 11(2009) Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. (29th August 2020) Authors: Fowkes, FGR; Murray, GD; Butcher, I; Folsom, AR; Hirsch, AT; Couper, DJ; DeBacker, G; Kornitzer, M; Newman, AB; Sutton-Tyrrell, KC; Cushman, M; Lee, AJ; Price, JF; D'Agostino, RB; Murabito, JM; Norman, PE; Masaki, KH; Bouter, LM; Heine, RJ; Stehouwer, CDA Journal: European journal of preventive cardiology Issue: Volume 21:Number 3(2014) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. (March 2014) Authors: Fowkes, FGR; Murray, GD; Butcher, I; Folsom, AR; Hirsch, AT; Couper, DJ; DeBacker, G; Kornitzer, M; Newman, AB; Sutton-Tyrrell, KC; Cushman, M; Lee, AJ; Price, JF; D'Agostino, RB; Murabito, JM; Norman, PE; Masaki, KH; Bouter, LM; Heine, RJ; Stehouwer, CDA Journal: European journal of preventive cardiology Issue: Volume 21:Number 3(2014) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials. (14th October 2021) Authors: Koenig, W; Ray, K K; Kallend, D G; Landmesser, U; Leiter, L A; Schwartz, G G; Wright, R S; Garcia Conde, L; Jaros, M; Raal, F J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials. (14th October 2021) Authors: Koenig, W; Ray, K K; Kallend, D G; Landmesser, U; Leiter, L A; Schwartz, G G; Wright, R S; Garcia Conde, L; Jaros, M; Raal, F J Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗